These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 4956802)

  • 1. New derivatives of rifamycin SV.
    Maggi N; Pallanza R; Sensi P
    Antimicrob Agents Chemother (Bethesda); 1965; 5():765-9. PubMed ID: 4956802
    [No Abstract]   [Full Text] [Related]  

  • 2. Antimicrobial properties of new derivatives of rifamycin SV.
    Furesz S; Arioli V; Pallanza R
    Antimicrob Agents Chemother (Bethesda); 1965; 5():770-7. PubMed ID: 4956803
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental antitubercular activity of rifampicin, a derivative of rifamycin SV].
    Grumbach F; Rist N
    Rev Tuberc Pneumol (Paris); 1967; 31(6):749-62. PubMed ID: 4988378
    [No Abstract]   [Full Text] [Related]  

  • 4. [Differentiation between Mycobacterium tuberculosis and Mycobacterium bovis by means of Rifamycin SV susceptibility].
    Tsukamura M; Tsukamura S
    Igaku To Seibutsugaku; 1966 Jun; 72(6):350-2. PubMed ID: 4959327
    [No Abstract]   [Full Text] [Related]  

  • 5. Novel rifamycins. I-Synthesis and antibacterial activity of 3-hydrazinorifamycin derivatives.
    Marsili L; Franceschi G; Gioia B; Oronzo G; Schioppacassi G; Vigevani A
    Farmaco Sci; 1982 Oct; 37(10):641-50. PubMed ID: 6814953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The activity in vitro of Rifamycin SV on various mycobacterial strains including tubercle bacilli isolated from patients never treated with Rifamycin SV.
    Tan THIAM HOK ; The KIE SENG ; Tan LIOE SAN ; Yang SHE YEN ; Widodo S
    Paediatr Indones; 1965; 5(1-2):12-4. PubMed ID: 4959746
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifampicin.
    Polascik M; Golden B
    Ann Ophthalmol; 1971 Aug; 3(8):877-82. PubMed ID: 5005929
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect on Mycobacterium tuberculosis of rifamycin SV alone and combined with major bacillostatic agents].
    Coletsos PJ
    Rev Tuberc Pneumol (Paris); 1967; 31(1):17-30. PubMed ID: 4962522
    [No Abstract]   [Full Text] [Related]  

  • 9. The biological studies on mitomycin I. Antibacterial activities of mitomycin derivatives.
    Miyamura S; Shigeno N; Matsui M; Wakaki S; Uzu K
    J Antibiot (Tokyo); 1967 Mar; 20(2):72-6. PubMed ID: 4964076
    [No Abstract]   [Full Text] [Related]  

  • 10. New rifabutin analogs: synthesis and biological activity against Mycobacterium tuberculosis.
    Barluenga J; Aznar F; García AB; Cabal MP; Palacios JJ; Menéndez MA
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5717-22. PubMed ID: 16987658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of the carboxyl group upon the antibacterial activity of rifamycins.
    Maggi N; Füresz S; Sensi P
    J Med Chem; 1968 Mar; 11(2):368-9. PubMed ID: 4969611
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental research on the antimycobacterial activity of rifampicine: 3-(4-methyl-l-piperazinyl-iminomethyl)-rifomycin SV].
    Lucchesi M; Mancini P; Zubiani M
    Ann Ist Carlo Forlanini; 1967; 27(2):119-36. PubMed ID: 4973676
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antimicrobial activity of derivates of benzoxazolinone].
    Tacquet A; Lespagnol C; Beerens H; Lesieur D; Devulder B
    Ann Inst Pasteur Lille; 1971; 22():189-200. PubMed ID: 5005654
    [No Abstract]   [Full Text] [Related]  

  • 14. Activity of the spiropiperidyl rifamycin LM 427 on rifampicin resistant Mycobacterium tuberculosis.
    Ungheri D; Della Bruna C; Sanfilippo A
    G Ital Chemioter; 1984; 31(3):211-4. PubMed ID: 6100178
    [No Abstract]   [Full Text] [Related]  

  • 15. The antituberculous activity of rifamycin SV.
    Nitti V
    Helv Med Acta; 1965 Dec; 32(6):603-24. PubMed ID: 4958120
    [No Abstract]   [Full Text] [Related]  

  • 16. History of the development of rifampin.
    Sensi P
    Rev Infect Dis; 1983; 5 Suppl 3():S402-6. PubMed ID: 6635432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent trends in rifamycin research.
    Lal R; Lal S
    Bioessays; 1994 Mar; 16(3):211-6. PubMed ID: 7513153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Growth of rifampin-dependent Mycobacterium tuberculosis in conditions without rifampin].
    Zhong M; Wang Y; Sun C; Yin H; Wang A; Zhong M; Lou L
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Oct; 25(10):588-90. PubMed ID: 12490123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [An investigation on multiple drug resistance of the rifampin resistant strains of Mycobacterium tuberculosis].
    Kuang T; Jin G; Song P; Li W; Wang Z
    Wei Sheng Wu Xue Bao; 1998 Apr; 38(2):152-4. PubMed ID: 12549378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similar effect of rifampin and other rifamycin derivatives on vaccinia virus morphogenesis.
    Grimley PM; Moss B
    J Virol; 1971 Aug; 8(2):225-31. PubMed ID: 4107245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.